Forensic Genomics Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, Method), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Forensic Genomics Market size was worth USD 755.6 million in 2026 and is expected to grow at a 14.16% CAGR between 2027 and 2036, crossing USD 2.84 billion by 2036. The industry revenue for 2027 is estimated at USD 845.67 million.
Get more details on this report
Request Free Sample ReportForensic Genomics Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for a 52.59% share in 2026, supported by advanced forensic laboratory infrastructure, DNA analysis adoption, and established investigation workflows.
- Asia Pacific is projected to grow at a 16.46% CAGR, driven by expanding forensic lab capacity and wider adoption of genomic evidence analysis.
Segment Momentum
- Kits & Consumables accounted for a 65.21% share in 2026 because every forensic sample requires routine reagents and preparation materials, creating steady demand across crime laboratories and forensic service providers.
- Paternity & Familial Testing is the fastest-growing application as genomic technologies are increasingly used for biological relationship verification, expanding forensic genomics into broader identity and kinship-based testing scenarios.
Market Expansion Drivers
- Increasing crime investigation requirements accelerating adoption of advanced DNA forensic testing solutions.
- Government funding for forensic laboratories supporting development of affordable genomic analysis technologies.
- Expansion of next-generation sequencing workflows improving forensic case resolution accuracy and efficiency.
Leading Market Participants
- Top companies in the forensic genomics market include Illumina, Inc. (United States), Thermo Fisher Scientific Inc. (United States), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Promega Corporation (United States), Bio-Rad Laboratories, Inc. (United States), Merck KGaA (Germany), Verogen, Inc. (United States), LGC Limited (United Kingdom), Eurofins Scientific SE (Luxembourg).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 755.6 million
- 2027 Estimated Market Size: USD 845.67 million.
- Projected Market Size: USD 2.84 billion by 2036
- Growth Forecast: 14.16% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Kits & Consumables (Product) | Criminal Testing (Application) | Capillary Electrophoresis (Method)
- Emerging Opportunity Segment: Software (Product) | Paternity & Familial Testing (Application) | Next-generation Sequencing (Method)
Market Growth Drivers and Industry Trends
Increasing crime investigation requirements accelerating adoption of advanced DNA forensic testing solutions
The expanding need for accurate identification and evidence analysis in criminal investigations will accelerate the forensic genomics market growth as law enforcement agencies seek more sophisticated DNA-based testing capabilities. Modern investigations increasingly depend on biological evidence obtained from crime scenes, missing-person cases, unidentified remains, and other forensic circumstances where conventional identification methods may provide limited information. Advanced genomic testing can enable laboratories to analyze challenging or limited biological samples and generate more informative genetic profiles for investigative purposes. Improvements in DNA extraction, profiling, interpretation, and evidence processing are also helping forensic laboratories manage complex casework while supporting more reliable comparisons between recovered biological material and available reference samples.
Government funding for forensic laboratories supporting development of affordable genomic analysis technologies
Public investment in forensic laboratory infrastructure is creating conditions for wider adoption of cost-efficient genomic technologies, supporting the forensic genomics market through improvements in testing capacity and laboratory capabilities. Government-funded programs can facilitate the modernization of forensic facilities, acquisition of advanced analytical equipment, workforce development, and implementation of improved evidence-processing workflows. Greater attention to laboratory affordability is also encouraging technology developers and forensic institutions to pursue solutions that can deliver dependable genomic analysis without placing excessive pressure on laboratory resources. Such investments can expand access to sophisticated testing capabilities across forensic facilities with different levels of operational capacity.
Expansion of next-generation sequencing workflows improving forensic case resolution accuracy and efficiency
The increasing use of next-generation sequencing in forensic applications is strengthening the forensic genomics market by enabling laboratories to obtain more detailed genetic information from biological evidence. Compared with conventional approaches focused on a narrower set of genetic markers, sequencing-based workflows can support broader analysis of complex samples and provide additional information useful for forensic interpretation. These capabilities are particularly valuable when evidence is degraded, mixed, or otherwise difficult to analyze using traditional methods. As forensic laboratories refine sequencing workflows and integrate them with established DNA analysis procedures, improvements in data interpretation and evidence characterization can help investigators work through challenging cases with greater analytical efficiency.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing crime investigation requirements accelerating adoption of advanced DNA forensic testing solutions | 2.00% | High | North America, Europe | High | Near Term |
| Government funding for forensic laboratories supporting development of affordable genomic analysis technologies | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Expansion of next-generation sequencing workflows improving forensic case resolution accuracy and efficiency | 1.50% | Moderate | Europe, North America | Medium | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The forensic genomics market was led by North America, which accounted for a 52.59% share in 2026, reflecting advanced forensic science infrastructure, established genomics capabilities, and strong integration of molecular techniques into criminal investigations. Law enforcement and forensic laboratories increasingly use genetic analysis to support human identification, relationship testing, and the investigation of complex cases. Improvements in DNA analysis workflows and computational capabilities are enhancing the ability to process and interpret forensic evidence, while established laboratory networks support broader adoption of genomic methods. Continued attention to forensic accuracy, evidence integrity, and investigative efficiency further strengthens regional demand for advanced genomics technologies.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is witnessing the fastest growth as forensic capabilities expand and governments and investigative institutions invest in modern laboratory infrastructure. Increasing awareness of DNA-based identification is encouraging broader use of genomic methods in criminal investigations and related applications. Improvements in forensic laboratory capacity, technical expertise, and access to advanced sequencing and molecular analysis tools are supporting wider adoption. The region's expanding focus on strengthening investigative systems and improving the scientific reliability of forensic evidence is also creating favorable conditions for the integration of genomic technologies.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Driven CaseworkGermany emphasizes standardized forensic genomics practices supported by accredited laboratories and rigorous validation protocols. Forensic institutions in Germany increasingly adopt advanced sequencing technologies to strengthen analytical reliability while improving efficiency in criminal investigations.
France 🇫🇷
Criminal Investigation SupportFrance is expanding the application of forensic genomics across criminal investigations and judicial laboratories. Forensic organizations in France continue modernizing DNA analysis capabilities to improve identification accuracy while supporting efficient handling of complex biological evidence.
Italy 🇮🇹
Laboratory Modernization FocusItaly continues modernizing forensic laboratories through the adoption of advanced genomic technologies and automated sample processing. Forensic institutions in Italy are prioritizing reliable DNA analysis solutions that improve workflow consistency and support complex forensic case investigations.
Japan 🇯🇵
High-Precision IdentificationJapan prioritizes highly accurate forensic genomics solutions for human identification and criminal investigations. Laboratories in Japan continue expanding the use of advanced DNA analysis platforms that enhance evidence processing while maintaining strict quality assurance standards.
South Korea 🇰🇷
Integrated Forensic InnovationSouth Korea continues strengthening forensic genomics capabilities through investments in molecular diagnostics and digital laboratory infrastructure. Public forensic agencies in South Korea increasingly adopt advanced sequencing and automated workflows to improve evidence processing and investigative efficiency.
United States 🇺🇸
Advanced DNA AnalyticsThe U.S. forensic genomics market is advancing through broader adoption of next-generation sequencing and bioinformatics across forensic laboratories. Agencies continue investing in technologies that improve case resolution, complex DNA interpretation, and integration with digital forensic workflows.
Segment Leadership and Growth Trends
Forensic Genomics Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Kits & Consumables (Largest Segment) vs Software (Fastest-Growing Segment)
Kits & consumables dominated the forensic genomics market in 2026, representing a 65.21% share, due to their direct role in DNA extraction, amplification, profiling, and related forensic workflows. Standardized kits and laboratory consumables help forensic laboratories maintain reproducible processing and support efficient analysis of biological evidence. Continued reliance on DNA-based identification and the need for dependable laboratory workflows reinforce the segment's established position.
Software is gaining momentum as forensic genomics increasingly incorporates digital tools for data management, genomic analysis, interpretation, and workflow automation. Advanced software can help laboratories process complex genetic information more efficiently while supporting data organization and analytical consistency. Growing volumes of genomic information and increasing emphasis on digitalization within forensic laboratories are strengthening demand for specialized software solutions.
Application Segment Analysis: Criminal Testing (Largest Segment) vs Paternity & Familial Testing (Fastest-Growing Segment)
Criminal testing held the largest share of the forensic genomics market in 2026, accounting for 64.17% share, reflecting the central role of DNA analysis in identifying suspects, linking biological evidence to investigations, and supporting criminal justice processes. The ability of forensic genomics to provide highly specific genetic evidence makes it an important component of modern investigative workflows. Continued use of DNA profiling for evidence analysis and identification sustains demand within criminal testing applications.
Paternity & familial testing is expanding as genomic techniques become increasingly accessible for relationship analysis and family identification. DNA-based testing can provide reliable genetic comparisons for establishing biological relationships and supporting familial investigations. Growing awareness of genetic testing capabilities, alongside broader application of genomic analysis beyond criminal investigations, is creating additional demand for forensic genomics in familial testing.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Analyzers & Sequencers, Software, Kits & Consumables | Kits & Consumables | Software |
| Application | Criminal Testing, Paternity & Familial Testing, Others | Criminal Testing | Paternity & Familial Testing |
| Method | Capillary Electrophoresis, Next-generation Sequencing, PCR Amplification, Others | Capillary Electrophoresis | Next-generation Sequencing |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Leading companies in the forensic genomics market:
1. Illumina Inc. (United States)
2. Thermo Fisher Scientific Inc. (United States)
3. QIAGEN N.V. (Netherlands)
4. Agilent Technologies Inc. (United States)
5. Promega Corporation (United States)
6. Bio-Rad Laboratories Inc. (United States)
7. Merck KGaA (Germany)
8. Verogen Inc. (United States)
9. LGC Limited (United Kingdom)
10. Eurofins Scientific SE (Luxembourg)
The forensic genomics market is advancing through the adoption of next-generation sequencing technologies, AI-assisted analysis tools, and enhanced DNA profiling techniques. Market participants are investing in highly accurate and rapid forensic testing solutions to meet growing legal and investigative requirements. Regulatory compliance initiatives and continuous research in genetic analysis methodologies are also supporting long-term innovation across the forensic genomics market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Illumina Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| QIAGEN N.V. (Netherlands) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| Promega Corporation (United States) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Verogen Inc. (United States) | |||||||
| LGC Limited (United Kingdom) | |||||||
| Eurofins Scientific SE (Luxembourg). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Promega Corporation | Oct-24 | Promega Corporation developed a new enzyme in October 2024 designed to significantly reduce stutter artifacts in forensic DNA analysis workflows. The advancement improves the reliability and accuracy of DNA profiling results, strengthening analytical performance in forensic genomics applications and supporting higher-confidence interpretation of complex DNA evidence. |
| QIAGEN | May-24 | QIAGEN entered a collaboration with the FBI in May 2024 to develop a digital PCR assay compatible with its QIAcuity platform for forensic DNA analysis. The initiative aims to improve DNA quantification from human samples, enabling faster and more reliable processing of forensic evidence and reinforcing QIAGEN’s role in forensic identification technologies. |
| Bode Technology | Feb-24 | Bode Technology expanded its forensic capabilities in February 2024 by launching validated genome sequencing options for Forensic Investigative Genetic Genealogy (FIGG). The offering enhances access to accredited in-house forensic DNA services, strengthening advanced investigative workflows and expanding the use of genomic sequencing in forensic identification and case resolution. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Forensic Genomics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| End User | Government Forensic Laboratories, Private Forensic Laboratories, Law Enforcement Agencies, Medical & Legal Institutions |
| Sample Type | Blood & Body Fluids, Hair, Tissue & Bone, Saliva & Buccal Samples, Trace Biological Evidence |
| Procurement Model | Direct Procurement, Distributor & Reseller Procurement, Tender-Based Procurement, Managed Laboratory Services |
Forensic Genomics Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Criminal Justice Application Expansion |
|
| Forensic Laboratory Modernization Strategy |
|
| Ethical, Privacy and Data Governance Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much is the forensic genomics market worth?
What is the expected industry size of forensic genomics by 2036?
How are evolving forensic investigation requirements shaping technology adoption in the forensic genomics market?
Why is next-generation sequencing becoming a strategic investment for forensic laboratories?
Why are Kits & Consumables the largest product segment in the forensic genomics market?
Why is Paternity & Familial Testing the fastest-growing application in the forensic genomics market?
Why does North America dominate the forensic genomics market?
How is Asia Pacific becoming a fast-growing region for forensic genomics?
What are the key competitors in the forensic genomics landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization